PainTEQ has received a new US patent for its LinQ SI Joint Stabilization System aimed at alleviating sacroiliac (SI) joint pain.

The No. 12,121,458 patent protects design features aimed at improving the efficiency and precision of the procedure, along with the safety of the patient.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The newly granted patent introduces two main advancements in instrument alignment. Claims one to six detail the joint locator usage with a keying protrusion for alignment with the cannula through a guidance slot.

Claims seven to 12 extend the scope by reversing the roles, placing the protrusion on the cannula while the joint locator is designed with a channel to receive it.

With this latest patent, the company’s intellectual property portfolio includes advancements in alignment tools. The patented technologies are designed to decrease outcome variability, safeguard safety with intuitive, single-use designs, and streamline surgical workflows.

The system offers a minimally invasive solution for individuals suffering from sacroiliac disease. By inserting a single LinQ allograft into the SI joint, physicians can ease or even remove chronic pain following a comprehensive diagnostic process.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Patented instrumentation and a large graft window of the system are designed to foster an optimal environment for long-term fusion, with an emphasis on efficiency and precision.

PainTEQ Marketing and R&D director Jeremy Carr said: “PainTEQ’s mission is to transform SI joint dysfunction treatment, and this new patent underscores our commitment to delivering cutting-edge solutions that prioritise patient well-being.

“By continually innovating and expanding the capabilities of our LinQ System, we are setting new standards industrywide and improving quality of life for countless individuals who suffer from SI joint pain.”

SI joints can become inflamed due to hypermobility, where the ligaments allow excessive movement, or hypomobility, often caused by arthritis, which restricts movement and leads to bones rubbing together. Both conditions can result in significant pain.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact